
Reditux RA 1000mg Injection
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Rituximab (1000mg)
Overview Reditux RA 1000mg Injection
Rituximab 1000mg injection is indicated for various conditions including non-Hodgkin's lymphoma, rheumatoid arthritis, chronic lymphocytic leukemia, and certain vasculitides (granulomatosis with polyangiitis and microscopic polyangiitis). Administered intravenously under medical supervision, the dosage and frequency are determined by the treating physician based on the specific disease and individual patient response. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose may lead to severe adverse effects. Therapeutic benefits might not be immediately apparent, potentially taking weeks or months to manifest; discontinuation should only occur under professional guidance. Common side effects include headache, fatigue, swelling, infections, and alopecia. This medication can suppress blood cell production, increasing infection risk, necessitating regular blood tests including monitoring for hepatitis B. Prior to treatment, disclose any pre-existing cardiac or hepatic conditions, planned surgical procedures or immunizations, and all concurrent medications, as drug interactions are possible. Use during pregnancy or breastfeeding is contraindicated, and effective contraception for both partners is strongly recommended throughout the treatment period.
Uses of Reditux RA 1000mg Injection
Chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis, microscopic polyangiitis, and non-Hodgkin's lymphoma.
Major Benefits of Reditux RA 1000mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Reditux RA 1000mg Injection:
- Headache
- Weakness
- Infection
- Chills
- Decreased white blood cell count (neutrophils)
- Fever
- Infusion site reaction
- Lymphopenia
- Abdominal pain
- Back pain
How to use Reditux RA 1000mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
How Reditux RA 1000mg Injection works:
Ruxolitinib 1000mg injection, a targeted monoclonal antibody therapy, neutralizes aberrant B-cell activity in rheumatoid arthritis and selected malignancies.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Reditux RA 1000mg Injection requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Reditux RA 1000mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible hazards prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Administration of Reditux RA 1000mg Injection during lactation is likely safe. Available human data indicate minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Reditux RA 1000mg Injection on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Employing Reditux RA 1000mg Injection in individuals with kidney impairment appears to pose minimal risk. Current evidence indicates dose modification for Reditux RA 1000mg Injection might be unnecessary in such cases. However, physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Reditux RA 1000mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised. Reditux RA 1000mg Injection is contraindicated in patients experiencing active liver disease or a history of viral hepatitis due to the risk of infection recurrence.
What if you forget to take Reditux RA 1000mg Injection :
Should you forget a dose of Reditux RA 1000mg Injection, seek advice from your physician.
Facts to Know About Reditux RA 1000mg Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Cancer Treatments |
| Action Category | Anti-CD20 Antibody |
